RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,739,421 | -32.4% | 801,358 | +0.9% | 0.00% | -50.0% |
| Q2 2023 | $9,975,504 | -30.6% | 794,228 | -9.0% | 0.00% | -33.3% |
| Q1 2023 | $14,368,790 | +9.0% | 872,422 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $13,181,488 | -27.9% | 882,295 | +7.9% | 0.00% | -25.0% |
| Q3 2022 | $18,294,000 | +36.7% | 817,835 | +2.4% | 0.00% | +33.3% |
| Q2 2022 | $13,383,000 | -31.2% | 798,949 | +22.8% | 0.00% | 0.0% |
| Q1 2022 | $19,464,000 | -7.4% | 650,351 | -5.0% | 0.00% | 0.0% |
| Q4 2021 | $21,018,000 | +15.8% | 684,390 | +18.8% | 0.00% | 0.0% |
| Q3 2021 | $18,158,000 | -5.0% | 575,928 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $19,104,000 | +24.4% | 522,106 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $15,355,000 | +3.8% | 444,133 | +24.8% | 0.00% | 0.0% |
| Q4 2020 | $14,791,000 | -3.0% | 355,893 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $15,249,000 | – | 358,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |